SHH:600186

Lotus Health Group Company · SHH · Consumer Defensive · CNY · FY for 2025

Figures on this page computed 2026-11-07 23:06 UTC

Last close

n/aCNY

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

51.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
22.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
8.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
6.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.56Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Price is the furthest below its sector's middle: 0.16 against 0.55 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.69x

6.12x

-2.25x

4.12x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.69x
Its own average over 10 years, 2.04B.
Profit6.12x
Its own average over 10 years, 50.5M.
Free cash flow-2.25x
Its own average over 10 years, -93.3M.
Debt4.12x
Its own average over 10 years, 268.8M.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 6.12 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	104.9	-158.5	95.1
2018-12-31	97.9	-509.6	98.1
2019-12-31	96.4	106.1	98.0
2020-12-31	93.7	113.9	105.2
2021-12-31	102.7	68.0	104.7
2022-12-31	95.7	70.8	109.0
2023-12-31	118.9	199.1	131.4
2024-12-31	149.8	310.5	119.5
2025-12-31	195.4	473.8	128.8

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CNY

Figures behind the shape

Growth

15.8%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate15.8%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
Five-year EPS growth rate27.7%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
One-year change in net income52.6%
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Returns on capital

22.6%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capital22.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity15.8%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets8.5%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

27.4%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin27.4%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin11.5%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin8.9%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin6.1%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

51.7x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earnings51.7x
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
Price to book8.2x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA29.5x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio4.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

0.56

safer is higher, placed against 3,227 companies as of 2026-11-06

Debt to equity0.56
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.72
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage10.5x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score6.61
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
CNY
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.